Reverse Medical Corp., an Irvine-based maker of devices for treating strokes, said Tuesday that it raised $14 million in a second round of venture funding.
Participating investors included Irvine-based MedFocus Fund, which founded and incubated Reverse Medical in 2007; Wexford Capital of Greenwich, Conn.; Cleveland-based Early Stage Partners; and BioStar Ventures, a Petoskey, Mich.-based fund.
Reverse Medical said it would use the money to help commercialize its microcatheters, which are medical devices used for things such as removing blood clots and restoring blood flow to patients who have suffered acute ischemic strokes.
MedFocus is led by Michael Henson, a longtime Orange County medical investor and entrepreneur who has participated in building a score of device makers.
They include Endologix Inc., which is based in Irvine and makes devices to treat ballooning blood vessels, and MiCardia Corp., also in Irvine, which is working on a mitral heart valve repair device.
